Article

Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride

External Link - PT0120_PeerReview_Patel(Watermark).pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
PharmTech Weekly News Roundup
Related Content
Close up shot pharmacist holding nasal spray medicine at the drugstore.Seasonal health issues | Image Credit: © I Viewfinder - stock.adobe.com
September 16th 2025

FDA Approves Cortasis Nasal Spray, Enbumyst, for Edema

Patrick Lavery
Drug Solutions Podcast: Sustainable Solutions for Biopharma
September 16th 2025

Drug Solutions Podcast: Sustainable Solutions for Biopharma

Patrick Lavery
Site Logo
September 16th 2025

Precision in miniature: optimizing multiparticulate formulations for pediatric oncology

Lonza
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
September 16th 2025

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
Digital composite of highlighted red painful liver of woman | Image credit: ©mi_viri -stock.adobe.com
September 16th 2025

Competition in MASH is Heating Up as GLP-1s Gate-Crash the Party

Cheryl Barton
Ana Ali, R&D Tax Consultant, RCK Partners
September 16th 2025

Op/Ed: Rethinking R&D Tax Relief–Why Smarter Incentives Are Key to Unlocking UK Pharma Innovation

Ana Ali
© 2025 MJH Life Sciences

All rights reserved.